We first elucidated the functional significance of SMURF2 in maintaining GSCs in vitro by targeting SMURF2 expression using lentiviral shRNA (shSMURF2) in TGS-01 and TGS-04 GSCs, which are human GBM patient-derived GSCs. This evidence concerns the gene SMURF2 and glioblastoma.